Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71026 - 71050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	HRH1	3269	upregulated	Silicon Dioxide results in increased expression of HRH1 mRNA	3p25.3	A24196
Silicon dioxide	Approved	HRK	8739	upregulated	Silicon Dioxide analog results in increased expression of HRK mRNA	12q24.22	A24195
Silicon dioxide	Approved	HS1BP3	64342	upregulated	Silicon Dioxide analog results in increased expression of HS1BP3 mRNA	2p24.1	A24195
Silicon dioxide	Approved	HS3ST1	9957	downregulated	Silicon Dioxide analog results in decreased expression of HS3ST1 mRNA	4p15.33	A24195
Silicon dioxide	Approved	HS3ST1	9957	upregulated	Silicon Dioxide results in increased expression of HS3ST1 mRNA	4p15.33	A24196
Silicon dioxide	Approved	HS3ST2	9956	upregulated	Silicon Dioxide analog results in increased expression of HS3ST2 mRNA	16p12.2	A24194
Silicon dioxide	Approved	HS3ST2	9956	upregulated	Silicon Dioxide results in increased expression of HS3ST2 mRNA	16p12.2	A24196
Silicon dioxide	Approved	HS3ST3B1	9953	downregulated	Silicon Dioxide analog results in decreased expression of HS3ST3B1 mRNA	17p12	A24195
Silicon dioxide	Approved	HS6ST1	9394	downregulated	Silicon Dioxide analog results in decreased expression of HS6ST1 mRNA	2q14.3	A24195
Silicon dioxide	Approved	HS6ST2	90161	upregulated	Silicon Dioxide analog results in increased expression of HS6ST2 mRNA	Xq26.2	A24194
Silicon dioxide	Approved	HSD11B1	3290	upregulated	Silicon Dioxide results in increased expression of HSD11B1 mRNA	1q32.2	A24196
Silicon dioxide	Approved	HSD11B2	3291	downregulated	Silicon Dioxide results in decreased expression of HSD11B2 mRNA	16q22.1	A24196
Silicon dioxide	Approved	HSD17B1	3292	downregulated	Silicon Dioxide analog results in decreased expression of HSD17B1 mRNA	17q21.2	A24195
Silicon dioxide	Approved	HSD17B14	51171	upregulated	Silicon Dioxide analog results in increased expression of HSD17B14 mRNA	19q13.33	A24195
Silicon dioxide	Approved	HSF2BP	11077	upregulated	Silicon Dioxide analog results in increased expression of HSF2BP mRNA	21q22.3	A24195
Silicon dioxide	Approved	HSF2BP	11077	downregulated	Silicon Dioxide results in decreased expression of HSF2BP mRNA	21q22.3	A24196
Silicon dioxide	Approved	HSP90AA1	3320	upregulated	Silicon Dioxide results in increased expression of HSP90AA1 mRNA	14q32.31	A24196
Silicon dioxide	Approved	HSPA12A	259217	upregulated	Silicon Dioxide results in increased expression of HSPA12A mRNA	10q25.3	A24196
Silicon dioxide	Approved	HSPA12B	116835	upregulated	Silicon Dioxide analog results in increased expression of HSPA12B mRNA	20p13	A24195
Silicon dioxide	Approved	HSPA1A	3303	upregulated	Silicon Dioxide analog results in increased expression of HSPA1A mRNA	6p21.33	A24195
Silicon dioxide	Approved	HSPA1A	3303	upregulated	Silicon Dioxide results in increased expression of HSPA1A mRNA	6p21.33	A24197 A24196
Silicon dioxide	Approved	HSPA1L	3305	upregulated	Silicon Dioxide results in increased expression of HSPA1L mRNA	6p21.33	A24196
Silicon dioxide	Approved	HSPA2	3306	upregulated	Silicon Dioxide results in increased expression of HSPA2 mRNA	14q23.3	A24196
Silicon dioxide	Approved	HSPA4	3308	upregulated	Silicon Dioxide results in increased expression of HSPA4 mRNA	5q31.1	A24196
Silicon dioxide	Approved	HSPA5	3309	upregulated	Silicon Dioxide analog results in increased expression of HSPA5 mRNA	9q33.3	A24210

Displaying entries 71026 - 71050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability